Merck & Co Inc (NYSE:MRK)
| 79.97 Delayed Data As of Jan 21 |  -0.78 / -0.97%Today’s Change | 68.38 Today|||52-Week Range 91.40 | +4.34% Year-to-Date |
Latest MRK News | Press Releases
Today’s Trading
| Previous close | 80.75 |
| Today’s open | 80.80 |
| Day’s range | 79.26 - 81.51 |
| Volume | 18,461,735 |
| Average volume (3 months) | 15,517,285 |
| Market cap | $202.0B |
Data as of 5:12pm ET, 01/21/2022
Growth & Valuation
| Earnings growth (last year) | -27.21% |
| Earnings growth (this year) | +2.32% |
| Earnings growth (next 5 years) | +12.50% |
| Revenue growth (last year) | +3.06% |
| P/E ratio | 24.0 |
| Price/Sales | 4.33 |
| Price/Book | 7.99 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | -1.14 | -1.29% |
| AZNAstraZeneca | -1.07 | -1.78% |
| LLYEli Lilly and Co | -0.07 | -0.03% |
| ABBVAbbVie | -1.02 | -0.77% |
Data as of 4:42pm ET, 01/21/2022
Financials
| Next reporting date | February 3, 2022 |
| EPS forecast (this quarter) | $1.53 |
| Annual revenue (last year) | $48.0B |
| Annual profit (last year) | $7.1B |
| Net profit margin | 14.72% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
Forecasts
